UTX and Its Role in Type 1 Diabetes
Author Information
Author(s): Chen Ho-Chung, Wang Hsing Hui, Kohn Lisa A., Sailer David, Zhang Shirley, McCarthy Ethan, Seyedsadr Maryam, Zhou Zikang, Yin Xihui, Wilkinson Nicole, Ortega Jessica, Lechner Melissa G., Hugo Willy, Su Maureen A.
Primary Institution: Cold Spring Harbor Laboratory
Hypothesis
UTX regulates the differentiation of autoreactive CD8+ T cell progenitors into cytolytic effectors in Type 1 Diabetes.
Conclusion
The study found that UTX deletion in T cells prevents the development of autoimmune diabetes by impairing the conversion of progenitor T cells to cytolytic effectors.
Supporting Evidence
- UTX deletion in T cells impairs the conversion of progenitor T cells to autoimmune effectors.
- Mice lacking UTX in T cells are protected from spontaneous diabetes.
- Short-term treatment with UTX inhibitor GSKJ4 protects against Type 1 Diabetes.
Takeaway
This study shows that a protein called UTX helps certain immune cells become more aggressive in attacking the body in Type 1 Diabetes, and blocking UTX could help prevent this.
Methodology
The researchers used mouse models to study the effects of UTX deletion and inhibition on T cell differentiation and autoimmune diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website